Apr 13, 2026 7:05 am EDT NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
Mar 16, 2026 7:05 am EDT NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
Feb 25, 2026 7:05 am EST NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types
Feb 12, 2026 7:05 am EST NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection
Jan 27, 2026 7:05 am EST NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
Jan 5, 2026 7:05 am EST NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
